Closed
Funding for Company-driven RNA Innovation (AReNA)
Supports company-driven RNA innovation
Last Update: April 29, 2026
Funding available
Varies by project
Timeline
- Closing date : March 30, 2026
Location
Quebec, Canada
Overview
This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop a new product or service
- Conduct research and development activities
- Launch or market a product/service
Eligible Funding
- Varies by project
Timeline
- Closing date : March 30, 2026
Eligible candidates
Eligible Industries
- Manufacturing
- Professional, scientific and technical services
- Health care and social assistance
Location
- Quebec
Legal structures
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Development of innovative technologies for the RNA therapy sector.
- Commercialization of Québec biopharmaceutical innovations.
Eligibility
Eligible geographic areas
- Quebec
Processing and Agreement
- A non-selective letter of intent is submitted first.
- Complete applications are then submitted for review.
- Applications are sent by email to appliquez-apply@cqdm.org.
Additional information
- The program is funded by the Ministry of Economy, Innovation and Energy (MEIE).
- It is managed by CQDM as part of AReNA, Québec’s RNA Hub.
- Applicants are directed to the AReNA website for full program details.
Contacts
Frequently Asked Questions about the Funding for Company-driven RNA Innovation (AReNA) Program
What is the Funding for Company-driven RNA Innovation (AReNA)?
This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.
What expenses are eligible under Funding for Company-driven RNA Innovation (AReNA)?
Development of innovative technologies for the RNA therapy sector.
Commercialization of Québec biopharmaceutical innovations.
Who can I contact for more information about the Funding for Company-driven RNA Innovation (AReNA)?
You can contact Quebec Consortium for Drug Discovery (CQDM) by email at appliquez-apply@cqdm.org.
Where is the Funding for Company-driven RNA Innovation (AReNA) available?
The Funding for Company-driven RNA Innovation (AReNA) program is available the province of Quebec.
Is the Funding for Company-driven RNA Innovation (AReNA) a grant, loan, or tax credit?
Funding for Company-driven RNA Innovation (AReNA) is a Other Support
Who are the financial supporters of the Funding for Company-driven RNA Innovation (AReNA)?
Funding for Company-driven RNA Innovation (AReNA) is funded by Quebec Consortium for Drug Discovery (CQDM)